Skip to main content
. 2019 Jul 8;9(8):e01357. doi: 10.1002/brb3.1357

Table 1.

Demographic and clinical characteristics

  HC group (n = 19) SZ group (n = 19) Statistics
Mean ± SD Range Mean ± SD Range   p
Gender, male/femalea, n 7/12   9/10   χ 2 = 0.43 0.45
Ageb 41.89 ± 10.25 30–60 44.16 ± 7.98 34–60 t = −0.76 0.74
Duration of illness, years     18.58 ± 10.12      
PANSS positive     14.05 ± 5.78      
PANSS negative     18.16 ± 5.70      
PANSS general psychopathology     32.53 ± 10.36      
PANSS total     64.74 ± 20.11      
Medication, CPZ equivalent (mg/day)     642.26 ± 330.66      
Verbal memoryb, z‐score −0.04 ± 0.12   −2.17 ± 1.30   t = 5.25 0.00
Digit sequencingb, z‐score 0.21 ± 0.94   −1.52 ± 0.95   t = 5.63 0.00
Token motor taskb, z‐score 0.19 ± 0.90   −1.88 ± 1.62   t = 4.89 0.00
Verbal fluencyb, z‐score 0.37 ± 1.00   −1.31 ± 1.11   t = 4.88 0.00
Symbol coding taskb, z‐score 0.92 ± 1.10   −1.86 ± 1.97   t = 5.38 0.00
Tower of Londonb, z‐score 0.04 ± 0.94   −1.72 ± 2.19   t = 3.22 0.00
Composite scoreb, z‐score 0.28 ± 0.78   −1.74 ± 1.17   t = 6.25 0.00

Abbreviations: CPZ, chlorpromazine; HC, healthy controls; n, number; PANSS, Positive and Negative Syndrome Scale; SD, standard deviation; SZ, schizophrenia.

a

Chi‐square test.

b

Independent‐samples t test.